Arokast-FT

Clinical Trials

Extensive clinical trials have demonstrated Montelukast's efficacy and safety for asthma and allergic rhinitis across various age groups, supporting its use as a preventive and maintenance therapy.

Lab Monitoring

• No routine laboratory monitoring is typically required. Liver function tests may be considered if symptoms of hepatic dysfunction develop.

Doctor Notes

• Counsel patients and caregivers on the potential for neuropsychiatric events and the importance of prompt reporting of any such symptoms.
• Stress that Montelukast is for prophylaxis and chronic treatment, not for acute asthma attacks. Patients should have a rescue inhaler available.
• Advise patients to take the tablet in the evening for optimal effect, or before exercise as appropriate.

Patient Guidelines

• Take this medicine regularly, even if you feel well.
• Do not use for the relief of acute asthma attacks; for this, use an inhaled short-acting beta-agonist.
• Report any new or worsening neuropsychiatric symptoms, including mood changes, anxiety, agitation, aggression, depression, or suicidal thoughts, to your doctor immediately.

Missed Dose Advice

If a dose is missed, take it as soon as you remember. However, if it is almost time for your next scheduled dose, skip the missed dose and resume your regular dosing schedule. Do not take a double dose to make up for a missed one.

Driving Precautions

Montelukast may cause dizziness or drowsiness in some individuals. Patients should be advised to know how they react to this medication before driving or operating machinery.

Lifestyle Advice

• Avoid triggers for asthma and allergies (e.g., dust mites, pollen, pet dander).
• Maintain a healthy lifestyle with regular exercise and a balanced diet.
• Discuss smoking cessation if applicable.